JOHN MILLER: Open Payments
NPI 1932113719 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 11 payments from 8 companies in 2025. Trend: 2023 $586 · 2024 $433 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $85 |
| Abbott Laboratories | 1 | $49 |
| Exact Sciences Corporation | 2 | $32 |
| ABBVIE INC. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, ENSITE, LINZESS, Veozah, Ozempic, Cologuard Collection Kit, VOQUEZNA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
